Cargando…
Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disease, caused by mutations in the dystrophin gene, characterised by cycles of muscle degeneration, inflammation and regeneration. Recently, there has been renewed interest specifically in drugs that ameliorate muscle inflammation in DMD p...
Autores principales: | Riddell, Dominique O., Hildyard, John C. W., Harron, Rachel C. M., Hornby, Natasha L., Wells, Dominic J., Piercy, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789403/ https://www.ncbi.nlm.nih.gov/pubmed/36444978 http://dx.doi.org/10.1242/dmm.049394 |
Ejemplares similares
-
Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy
por: Riddell, Dominique O., et al.
Publicado: (2022) -
The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy
por: Hildyard, John C.W., et al.
Publicado: (2022) -
Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy
por: Hornby, Natasha L., et al.
Publicado: (2021) -
Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy
por: Crawford, Abbe H., et al.
Publicado: (2022) -
Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter
por: Crawford, Abbe H., et al.
Publicado: (2023)